1. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. WHO Technical Report Series 894, Geneva, 2000.
2. James, W. P. T., Rigby, N., Leach, R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur. J. Cardiovasc. Prev. Rehabil., 2004; 11: 3–8.
3. Haslam, D. W., James, W. P. T. Obesity. Lancet, 2005; 366: 1197–1209.
4. Chan, J. M., Rim, E. B., Colditz, G. A., Stampfer, M. J., Willett, W. C. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabet Care, 1994; 17: 961–969.
5. Colditz, G. A., Willett, W. C., Rotnitzky, A., Manson, J. E. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann. Int. Med., 1995; 122: 481–486.
6. Banegas, J. R., Polez-Garcia, E., Gutierrez-Fisac, J. L., Guallar-Castillon, P., Rodriguez-Artalejo, F. A simple estimate of mortality attributable to excess weight in the European Union. Eur. J. Clin. Nutr., 2003; 57: 201–208.
7. Poulose, B. K., Holman, M. D., Zhu, Y., et al. National variations in morbid obesity and bariatric surgery use. J. Am. Coll. Surg., 2005; 201: 77–84.
8. Adams, K. F., Schatzkin, A., Hartus, T. B., et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. New Engl. J. Med., 2006; 355: 763–768.
9. Drenick, E. J., Bale, G. S., Seltzer, F., Johnson, D. G. Excessive mortality and cause of death in morbidly obese men. JAMA, 1980; 243: 443–444.
10. von Lengerke, T., Reitmeir, P., John, J. Direct medical costs of (severe) obesity: a bottom-up assessment of over- vs. normal-weight adults in the KORA-study region (Augsburg, Germany). Gesundheitswesen, 2006; 68: 110–115.
11. National Conference of State Legislatures Vol. 13, No. 32. (www.ncsl.org)
12. Buchwald, H. Bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. J. Am. Coll. Surg., 2005; 200: 593–604.
13. Buchwald, H., Avidor, Y., Braunwald, E., et al. Bariatric surgery: A systematic review and meta-analysis. JAMA, 2004; 292: 1724–1737.
14. Cancello, R., Henegar, C., Viguerie, N., et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes, 2005; 54: 2277–2286.
15. Special Report: Commonwealth of Massachusetts Betsy Lehman Center for Patient Safety and Medical Error Reduction Expert Panel on Weight Loss Surgery. Obes. Res., 2005; 13: 205–226.
16. Sauerland, S., Angrisani, L., Belachew, M., et al. Obesity Surgery. Evidence based guidelines of the EAES. Surg. Endosc., 2005; 19: 200–221.
17. Maggard, M. A., Shugarman, M. L., Suttorp, M., et al. Meta-Analysis: Surgical treatment of obesity. Ann. Int. Med., 2005; 142: 547–559.
18. Laville, M., Romon, M., Chavrier, G., et al. Recommendations Regarding Obesity Surgery. Obes. Surg., 2005; 15: 1476–1480.
19. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann. Intern. Med., 1991; 115: 956–961.
20. Ridley, N. Expert panel on weight loss surgery – Executive report. Obes. Res., 2005; 13: 206–226.
21. Andersen, T., Backer, O. G., Stokholm, K. H., et al. Randomized trial of diet and gastroplasty compared with diet alone in morbid obesity. New Engl. J. Med., 1984; 310: 352–356.
22. Andersen, T., Stokholm, K. H., Backer, O. G., et al. Long term (5-year) results after either horizontal gastroplasty or very low-calorie diet for morbid obesity. Int. J. Obes., 1988; 12: 277–284.
23. Karason, K., Lindroos, A. K., Stenlof, K., et al. Relief of cardiorespiratory symptoms and increased physical activity after surgically induced weight loss: results from the Swedish Obese Subjects study. Arch. Intern. Med., 2000; 160: 1797–1802.
24. Karlsson, J., Sjostrom, L., Sullivan, M. Swedish obese subjects (SOS) an intervention study of obesity. Two—year follow-up of health-related quality of life (HRQL) and eating behavior after gastric surgery for severe obesity. Int. J. Obes. Relat. Metab. Disord., 1998; 22: 113–126.
25. Fernandez, A. Z. Jr., Demaria, E. J., Tichansky, D. S., et al. Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann. Surg., 2004; 239: 698–703.
26. Sjostrom, C. D., Peltonen, M., Wedel, H., et al. Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension, 2000; 36: 20–25.
27. Sjostrom, C. D., Lissner, I., Wedel, H., et al. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes. Res., 1999; 7: 477–484.
28. Christou, N. V., Sampalis, J. S., Liberman, M., et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann. Surg., 2004; 240: 416–423.
29. Mun, E. C., Blackburn, G. L., Matthews, J. B. Current status of medical and surgical therapy for obesity. Gastroenterology, 2001; 120: 669–681.
30. Flum, D. R., Dellinger, E. Impact of gastric bypass on survival: a population-based analysis. J. Am. Coll. Surg., 2004; 199: 543–551.
31. American College of Endocrinology (ACE), American Association of Clinical Endocrinologists (AACE). AACE/ACE position statement on the prevention, diagnosis and treatment of obesity. Jacksonville (FL): American Association of Clinical Endocrinologists. Endocr. Pract., 1998; 4: 297–350.
32. American Society for Bariatric Surgery, Society of American Gastrointestinal Endoscopic Surgeons. Guidelines for laparoscopic and open surgical treatment of morbid obesity. Obes. Surg., 2000; 10: 378–379.
33. Douketis, J. D., Feightner, J. W., Attia, J., et al. Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity. Canadian Task Force on Preventive Health Care. CMAJ, 1999; 160: 513–525.
34. International Federation for the Surgery of Obesity. Statement on patient selection for bariatric surgery. Obes. Surg., 1997; 7: 41.
35. Lauterbach, K., Westenhofer, J., Wirth, A., et al. Evidenzbasierte Leitlinie zur Behandlung der Adipositas in Deutschland. Köln: Otto Hauser, 1998.
36. Msika, S. Surgery for morbid obesity: 2. Complications. Results of a Technologic Evaluation by the ANAES. J. Chir. (Paris), 2003; 140: 4–21.
37. National Institute for Clinical Excellence. Guidance on the use of surgery to aid weight reduction for people with morbid obesity (Technology Appraisal No. 46). National Institute for Clinical Excellence, London, 2002.
38. Apovian, C. M., Baker, C., Ludwig, D. S., et al. Best practice guidelines in pediatric/adolescent weight loss surgery. Obes. Res., 2005; 13: 274–282.
39. Inge, T. H., Krebs, N. F., Garcia, V. F., et al. Bariatric surgery for severely overweight adolescens: concerns and recommendations. Pediatrics, 2004; 114: 217–223.
40. Sugerman, H. J., Superman, E. L., DeMaria, E. J., et al. Bariatric surgery for severely obese adolescents. J. Gastrointest. Surg., 2003; 7: 102–107.
41. Dolan, K., Creighton, L., Hopkána, G., et al. Laparoscopic gastric banding in morbidly obese adolescents. Obes. Surg., 2003; 13: 101–104.
42. Stanford, A., Glascock, J. M., Eid, G. M., et al. Laparoscopic Roux-en-Y gastric bypass in morbidly obese adolescents. J. Pediatr. Surg. 2003; 38: 430–433.
43. Widhalm, K., Dietrich, S., Prager, G. Adjustable gastric banding surgery in morbidly obese adolescents: Experience with 8 patients. Int. J. Obes., 2004; 28: 42S–48S.
44. Silberhummer, G. R., Miller, K., Kriwanek, S., et al. Laparoscopic adjustable gastric banding in adolescents: The Austrian experience. Obes. Surg., 2006; 16: 1062–1067.
45. Capella, J. F., Capella, R. F. Bariatric surgery in adolescence: is this the best age to operate? Obes. Surg., 2003; 13: 826–832.
46. Patterson, E. J., Urbach, D. R., Swanstrom, L. L. A comparison of diet and exercise therapy versus laparoscopic Roux-en-Y gastric bypass surgery for morbid obesity: a decision analysis model. J. Am. Coll. Surg., 2003; 196: 379–384.
47. Averbukh, Y., Heshka, S., El-Shoreya, H., et al. Depression score predicts weight loss following Roux-en-Y gastric bypass. Obes Surg 2003;13:833–6.
48. Ray, E. C., Nickels, M. W., Sayeed, S., et al. Predicting success after gastric bypass: the role of psychosocial and behavioral factors. Surgery 2003;134:555–564.
49. Charles SC. Psychiatric evaluation of morbidly obese patients. Gastroenterol. Clin. North Am., 1987; 16: 415–432.
50. Gertler, R., Ramsey-Stewart, G. Pre-operative psychiatric assessment of patients presenting for gastric bariatric surgery (surgical control of morbid obesity). Aust. N Z J. Surg., 1986; 56: 157–161.
51. Guisado, J. A., Vaz, F. J., Lopez-Ibor, J. J., et al. Gastric surgery and restraint from food as triggering factors of eating disorders in morbid obesity. Int. J. Eat Disord., 2002; 31: 97–100.
52. Sogg, S., Mori, D. L. The Boston interview for gastric bypass: determining the psychological suitability of surgical candidates. Obes. Surg., 2004; 14: 370–380.
53. Ferraro, D. R. Preparing patients for bariatric surgery – the clinical considerations. Clinician Reviews, 2004; 14: 57–63.
54. Naef, M., Sadowski, C., de Marco, D., et al. Die vertikale Gastroplastik nach Mason zur Behandlung der morbiden Adipositas: Ergebnisse einer prospektiven klinischen Studie. Chirurg, 2000; 71: 448–455.
55. Wiesner, W., Schod, O., Hauser, R. S., et al. Adjustable laparoscopic gastric banding in patients with morbid obesity: radiographic management, results, and postoperative complications. Radiology, 2000; 216: 389–394.
56. Schumann, R., Jones, S. B., Ortiz, V. E., et al. Best practice recommendations for anesthetic perioperative care and pain management in weight loss surgery. Obes. Res., 2005; 13: 254–266.
57. O’Keefe, T., Patterson, E. J. Evidence supporting routine polysomnography before bariatric surgery. Obes. Surg., 2004; 14: 23–26.
58. Sugerman, H. J., Fairman, R. P., Baron, P. L., et al. Gastric surgery for respiratory insufficiency of obesity. Chest, 1986; 90: 81–86.
59. Sugerman, H. J., Fairman, R. P., Sood, R. K., et al. Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am. J. Clin. Nutr., 1992; 55: 597S–601S.
60. Miller, K., Hell, E. Laparoscopic surgical concepts of morbid obesity. Langenbecks Arch. Surg., 2003; 388: 375–384.
61. Naef, M., Sadowski, C., de Marco, D., et al. Die vertikale Gastroplastik nach Mason zur Behandlung der morbiden Adipositas: Ergebnisse einer prospektiven klinischen Studie. Chirurg, 2000; 71: 448–455.
62. Gonzalez, R., Bowers, S. P., Venkatesh, K. R., et al. Preoperative factors predictive of complicated postoperative management after Roux-en-Y gastric bypass for morbid obesity. Surg. Endosc., 2003; 17: 1900–1914.
63. Frey, W. C., Pilcher, J. Obstructive sleep-related breathing disorders in patients evaluated for bariatric surgery. Obes. Surg., 2003; 13: 676–683.
64. Sharaf, R. N., Weinshel, E. H., Bini, E. J., et al. Radiologic assessment of the upper gastrointestinal tract: does it play an important preoperative role in bariatric surgery? Obes. Surg., 2004; 14: 313–317.
65. Jaffin, B. W., Knoepflmacher, P., Greenstein, R. High prevalence of asymptomatic esophageal motility disorders among morbidly obese patients. Obes. Surg., 1999; 9: 390–395.
66. Frigg, A., Peterli, R., Zynamon, A., et al. Radiologic and endoscopic evaluation for laparoscopic adjustable gastric banding: preoperative and follow-up. Obes. Surg., 2001; 11: 594–599.
67. Greenstein, R. J., Nissan, A., Jaffin, B. Esophageal anatomy and function in laparoscopic gastric restrictive bariatric surgery: implications for patient selection. Obes. Surg., 1998; 8: 199–206.
68. Verset, D., Houben, J. J., Gay, F., et al. The place of upper gastrointestinal tract mendoscopy before and after vertical banded gastroplasty for morbid obesity. Dig. Dis. Sci., 1997; 42: 2333–2337.
69. Saltzman, E., Anderson, W., Apovian, C. M., et al. Criteria for patient selection and multidisciplinary evaluation and treatment of the weight loss surgery patient. Obes. Res., 2005; 13: 234–243.
70. Kelly, J., Tarnoff, M., Shikora, S., et al. Best Practice Recommendations for Surgical Care in Weight Loss Surgery. Obes. Res., 2005; 13: 227–233.
71. Brolin, R. E. Bariatric surgery and long-term control of morbid obesity. JAMA, 2002; 288: 2793–2796.
72. Mun, E. C., Blackburn, G. L., Matthews, J. B. Current status of medical and surgical therapy for obesity. Gastroenterology, 2001; 120: 669–681.
73. Murr, M. M., Balsiger, B. M., Kennedy, F. P., et al. Malabsorptive procedures for severe obesity: comparison of pancreaticobiliary bypass and very very long limb Roux-en-Y gastric bypass. J. Gastrointest. Surg., 1999; 3: 607–612.
74. Scopinaro, N., Gianetta, E., Adami, G. F., et al. Biliopancreatic diversion for obesity at eighteen years. Surgery, 1996; 119: 261–268.
75. Scopinaro, N., Marinari, G. M., Camerini, G. Laparoscopic standard biliopancreatic diversion: technique and preliminary results. Obes. Surg., 2002; 12: 362–365.
76. Howard, L., Malone, M., Michalek, A., et al. Gastric bypass and vertical banded gastroplasty – a prospective randomized comparison and 5-year follow-up. Obes. Surg., 1995; 5: 55–60.
77. van Dielen, F. M., Soeters, P. B., de Brauw, L. M., et al. Laparoscopic adjustable gastric banding versus open vertical banded gastroplasty: A prospective randomized trial. Obes. Surg., 2005; 15: 1292–1298.
78. Brolin, R. E., Kenler, H. A., Gorman, J. H., et al. Long-limb gastric bypass in the superobese. A prospective randomized study. Ann. Surg., 1992; 215: 387–395.
79. Podnos, Y. D., Jimenez, J. C., Wilson, S. E., et al. Complications after laparoscopic gastric bypass: a review of 3464 cases. Arch. Surg., 2003; 138: 957–961.
80. Perugini, R. A., Mason, R., Czerniach, D. R., et al. Predictors of complication and suboptimal weight loss after laparoscopic Roux-en-Y gastric bypass: a series of 188 patients. Arch. Surg., 2003; 138: 541–545.
81. Nguyen, N. T., Rivers, R., Wolfe, B. M. Factors associated with operative outcomes in laparoscopic gastric bypass. J. Am. Coll. Surg., 2003; 197: 548–555.
82. Ren, C. J., Weiner, M., Allen, J. W. Favorable early results of gastric banding for morbid obesity: the American experience. Surg. Endosc., 2004; 18: 543–546.
83. Rubenstein, R. B. Laparoscopic adjustable gastric banding at a U.S. center with up to 3-year follow-up. Obes. Surg., 2002; 12: 380–384.
84. O’Brien, P. E., Dixon, J. B., Brown, W., et al. The laparoscopic adjustable gastric band (Lap-Band): a prospective study of medium-term effects on weight, health and quality of life. Obes. Surg., 2002; 12: 652–660.
85. Spivak, H., Favretti, F. Avoiding postoperative complications with the LAP-BAND system. Am. J. Surg., 2002; 184: 31S–37S.
86. Belachew, M., Belva, P. H., Desaive, C. Long-term results of laparoscopic adjustable gastric banding for treatment of morbid obesity. Obes. Surg., 2002; 12: 564–568.
87. DeMaria, E. J., Sugerman, H. J. A critical look at laparoscopic adjustable silicone gastric banding for surgical treatment of morbid obesity: does it measure up? Surg. Endosc., 2000; 14: 697–699.
88. Favretti, F., Cadiere, G. B., Segato, G., et al. Laparoscopic adjustable silicone gastric banding (Lap-Band): how to avoid complications. Obes. Surg., 1997; 7: 352–358.
89. Fried, M., Miller, K., Kormanova, K. Literature review of comparative studies of complications with Swedish band and Lap-Band. Obes. Surg., 2004; 14: 256–260.
90. Fried, M., Pešková, M., Kasalický, M. Assessment of the outcome of laparoscopic nonadjustable gastric banding and stoma adjustable gastric banding: surgeon’s and patient’s view. Obes. Surg., 1998; 8: 45–48.
91. Hall, J. C., Watts, J. M., O’Brien, P. E., et al. Gastric surgery for morbid obesity. The Adelaide Study. Ann. Surg., 1990; 211: 419–427.
92. Laws, H. L., Piantadosi, S. Superior gastric reduction procedure for morbid obesity: a prospective, randomized trial. Ann. Surg., 1981; 193: 334–340.
93. Bajardi, G., Ricevuto, G., Mastrandrea, G., et al. Surgical treatment of morbid obesity with biliopancreatic diversion and gastric banding: report on an 8-year experience involving 235 cases. Ann. Chir., 2000; 125: 155–162.
94. Chapman, A. E., Kiroff, G., Game, P., et al. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery, 2004; 135: 326–351.
95. Dolan, K., Hatzifotis, M., Newbury, L., et al. A comparison of laparoscopic adjustable gastric banding and biliopancreatic diversion in superobesity. Obes. Surg., 2004; 14: 165–169.
96. Jones, D. B., Provost, D. A., DeMaria, E. J., et al. Optimal management of the morbidly obese patient SAGES appropriateness conference statement. Surg. Endosc., 2004; 18: 1029–1037.
97. American Society for Bariatric Surgery 2004 Bariatric Surgery. ASBS guidelines. www.lapsurgery.com.
98. Society of American Gastrointestinal Endoscopic Surgeons. Guidelines for institutions granting bariatric priviledges utilizing laparoscopic techniques. SAGES and the SAGES Bariatric Task Force. Surg. Endosc., 2003; 17: 2037–2040.
99. Flum, D. R., Dellinger, E. P. Impact of gastric bypass operation on survival: a population-based analysis. J. Am. Col. Surg., 2004; 199: 543–551.
100. Schauer, P., Ikramuddin, S., Hamad, G., et al. The learning curve for laparoscopic Roux-en-Y gastric bypass is 100 cases. Surg. Endosc., 2003; 17: 212–215.
101. Wittgrove, A. C., Clark, G. W. Laparoscopic gastric bypass, Roux-en-Y – 500 patients: technique and results with 3–60 months follow-up. Obes. Surg., 2000; 10: 233–239.
102. Higa, K. D., Boone, K. B., Ho, T., et al. Laparoscopic Roux-en-Y gastric-bypass for morbid obesity: technique and preliminary results of our first 400 patients. Arch. Surg., 2000; 135: 1029–1033.
103. Courcoulas, A., Schuchert, M., Gatti, G., et al. The relationship of surgeon and hospital volume to outcome after gastric bypass surgery in Pennsylvania: a 3-year summary. Surgery, 2003; 134: 613–623.
104. Miller, K., Hell, E. Laparoscopic surgical concepts of morbid obesity. Langenbecks Arch. Surg., 2003; 388: 375–384.
105. Laville, M., Romon, M., Chavrier, G., et al. Recommendations regarding obesity surgery. Obes. Surg., 2005; 15: 1476–1480.
106. Shen, R., Dugay, G., Rajaram, K., et al. Impact of patient follow-up on weight loss after bariatric surgery. Obes. Surg., 2004; 14: 514–519.
107. Favretti, F., O’Brien, P. E., Dixon, J. B. Patient management after LAP-BAND placement. Am. J. Surg., 2002; 184: 38S–41S.
108. Busetto, L., Pisent, C., Segato, G., et al. The influence of a new timing strategy of band adjustment on the vomiting frequency and the food consumption of obese women operated with laparoscopic adjustable silicone gastric banding (LAP-BAND). Obes. Surg., 1997; 7: 505–512.
109. Rabkin, R. A., Rabkin, J. M., Metcalf, B., et al. Nutritional markers following duodenal switch for morbid obesity. Obes. Surg., 2004; 14: 84–90.
110. Ledikwe, J. H., Smiciklas-Wright, H., Mitchell, D. C., et al. Nutritional risk assessment and obesity in rural older adults: a sex difference. Am. J. Clin. Nutr., 2003; 77: 551–558.
111. Ledikwe, J. H., Smiciklas-Wright, H., Mitchell, D. C., et al. Dietary patterns of rural older adults are associated with weight and nutritional status. J. Am. Geriatr. Soc., 2004; 52: 589–595.
112. MacLean, L. D., Rhode, B., Shizgal, H. N. Nutrition after vertical banded gastroplasty. Ann. Surg., 1987; 206: 555–563.
113. Hamoui, N., Anthone, G., Crookes, P. F. Calcium metabolism in the morbidly obese. Obes. Surg., 2004; 14: 9–12.
114. Faintuch, J., Matsuda, M., Cruz, M. E., et al. Severe protein-calorie malnutrition after bariatric procedures. Obes. Surg., 2004; 14: 175–181.
115. Baltasar, A., Serra, C., Perez, N., et al. Clinical hepatic impairment after the duodenal switch. Obes. Surg., 2004; 14: 77–83.
116. Boylan, L. M., Sugerman, H. J., Driskell, J. A. Vitamin E, vitamin B6, vitamin B12, and folate status of gastric bypass surgery patients. J. Am. Diet. Assoc., 1988; 88: 579–585.
117. Cannizzo, F. Jr., Kral, J. G. Obesity surgery: a model of programmed undernutrition. Curr. Opin. Clin. Nutr. Metab. Care, 1998; 1: 363–368.
118. Hamoui, N., Kim, K., Anthone, G., et al. The significance of elevated levels of parathyroid hormone in patients with morbid obesity before and after bariatric surgery. Arch. Surg., 2003; 138: 891–897.
119. Skroubis, G., Sakellaropoulos, G., Pouggouras, K., et al. Comparison of nutritional deficiencies after Roux-en-Y gastric bypass and after biliopancreatic diversion with Roux-en-Y gastric bypass. Obes. Surg., 2002; 12: 551–558.
120. Slater, G. H., Ren, C. J., Siegel, N., et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J. Gastrointest. Surg., 2004; 8: 48–55.
121. Halverson, J. D. Micronutrient deficiencies after gastric bypass for morbid obesity. Am. Surg., 1986; 52: 594–598.
122. Avinoah, E., Ovnat, A., Charuzi, I. Nutritional status seven years after Roux-en-Y gastric bypass surgery. Surgery, 1992; 111: 137–142.
123. Brolin, R. E., Gorman, R. C., Milgrim, L. M., et al. Multivitamin prophylaxis in prevention of post-gastric bypass vitamin and mineral deficiencies. Int. J. Obes. Relat. Metab. Disord., 1991; 15: 661–667.
124. Rhode, B. M., Arseneau, P., Cooper, B. A., et al. Vitamin B-12 deficiency after gastric surgery for obesity. Am. J. Clin. Nutr., 1996; 63: 103–109.
125. Schilling, R. F., Gohdes, P. N., Harpie, G. H. Vitamin B12 deficiency after gastric bypass surgery for obesity. Ann. Intern. Med., 984; 101: 501–502.
126. Simon, S. R., Zemel, R., Betancourt, S., et al. Hematologic complications of gastric bypass for morbid obesity. South Med. J., 1989; 82: 1108–1110.
127. Brolin, R. E., Gorman, J. H., Gorman, R. C., et al. Are vitamin B12 and folate deficiency clinically important after Roux-en-Y gastric bypass? J. Gastrointest. Surg., 1998; 2: 436–442.
128. Halverson, J. D. Metabolic risk of obesity surgery and long term follow-up. Am. J. Clin. Nutr., 1992; 55: 602S–605S.
129. Goode, L. R., Brolin, R. E., Chowdhury, H. A., et al. Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes. Res., 2004; 12: 40–47.
130. Coates, P. S., Fernstrom, J. D., Fernstrom, M. H., et al. Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J. Clin. Endocrinol. Metab. 2004; 89: 1061–1065.
131. Shaker, J. L., Norton, A. J., Woods, M. F., et al. Secondary hyperparathyroidism and osteopenia in women following gastric exclusion surgery for obesity. Osteoporos. Int., 1991; 1: 177–181.
132. Abu-Abeid, S., Keidar, A., Gavert, N., et al. The clinical spectrum of band erosion following laparoscopicadjustable silicone gastric banding for morbid obesity. Surg. Endosc., 2003; 17: 861–863.
133. Jones, K. B. Jr. Revisional bariatric surgery-safe and effective. Obes. Surg., 2001; 11: 183–189.
134. Weber, M., Muller, M. K., Michel, J. M., et al. Laparoscopic Roux-en-Y gastric bypass, but not rebanding, should be proposed as rescue procedure for patients with failed laparoscopic gastric banding. Ann. Surg., 2003; 238: 827–834.
135. Dolan, K., Fielding, G. Biliopancreatic diversion following failure of laparoscopic adjustable gastric banding. Surg. Endosc., 2004; 18: 60–63.
136. Chevallier, J. M., Zinzindohoue, F., Douard, R., et al. Complications after laparoscopic adjustable gastric banding for morbid obesity: experience with 1,000 patients over 7 years. Obes. Surg., 2004; 14: 407–414.
137. Iovino, P., Angrisani, L., Tremolaterra, F., et al. Abnormal eso-phageal acid exposure is common in morbidly obese patients and improves after a successful Lap-band system implantation. Surg. Endosc., 2002; 16: 1631–1635.
138. Niville, E., Dams, A. Late pouch dilation after laparoscopic adjustable gastric and esophagogastric banding: incidence, treatment, and outcome. Obes. Surg., 1999; 9: 381–384.
139. Sanyal, A. J., Sugerman, H. J., Kellum, J. M., et al. Stomal complications of gastric bypass: incidence and outcome of therapy. Am. J. Gastroentero., 1992; 187: 1165–1169.
140. Schwartz, M. L., Drew, R. L., Roiger, R. W., et al. Stenosis of the gastroenterostomy after laparoscopic gastric bypass. Obes. Surg., 2004; 14: 484–491.
141. Barba, C. A., Butensky, M. S., Lorenzo, M., et al. Endoscopic dilation of gastroesophageal anastomosis stricture after gastric bypass. Surg. Endosc., 2003; 17: 416–420.
142. Schauer, P. R., Ikrammudin, S., Gourash, W., et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann. Surg., 2000; 232: 515–529.
143. Spaulding, L. Treatment of dilated gastrojejunostomy with sclerotherapy. Obes. Surg., 2003; 13: 254–257.
144. Anthone, G. J., Lord, R. V., DeMeester, T. R., et al. The duodenal switch operation for the treatment of morbid obesity. Ann. Surg., 2003; 238: 618–628.
145. Bloomberg, R. D., Urbach, D. R. Laparoscopic Roux-en-Y gastric bypass for severe gastroesophageal reflux after vertical banded gastroplasty. Obes. Surg., 2002; 12: 408–441.